Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 4 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Sept. 28, 2018 KRMD A 9,091 $1.65 $15,000 160,518 Direct +6.00% Acquired 79.4% (price as of 2026-10-02)
March 29, 2018 KRMD A 11,538 $1.30 $14,999 140,557 Direct +8.94% Acquired 127.7% (price as of 2026-10-02)
Dec. 29, 2017 KRMD A 12,000 $1.25 $15,000 129,019 Direct +10.25% Acquired 136.8% (price as of 2026-10-02)
Sept. 29, 2017 KRMD A 28,302 $0.53 $15,000 117,019 Direct +31.90% Acquired 458.5% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Initial ownership (Form 3) 1 holding

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
May 5, 2017 KRMD Common Stock 46,164 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

KRMD

Former Chief Medical Officer ( 5)
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2018 $303,800 · $45,000 · · · $225,000 $573,800
2017 $250,000 · $65,000 · $60,000 · · $375,000

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.